The CAPTURE Platform
Rapid Pathogen Identification & Antibiotic Susceptibility Testing (AST)
Key Facts
About GeneCapture
GeneCapture is pioneering a rapid, portable diagnostic platform designed to identify pathogens and determine antibiotic susceptibility in under two hours at the point of care. Its core technology, The CAPTURE Platform™, uses direct RNA hybridization (DRH) on a disposable cartridge to detect bacteria, viruses, fungi, and parasites without nucleic acid amplification (PCR). Targeting applications in clinical, community, agricultural, and military settings, the company aims to combat antimicrobial resistance and improve patient outcomes by providing actionable diagnostic data outside traditional lab environments. The platform is in development, with backing from entities like the Defense Health Agency.
View full company profile